Division of Movement Disorders, University of Louisville

Louisville, Kentucky 40202

0 studies enrolling now · 1 studies all time

What they study most

Progressive Supranuclear Palsy

Studies at this site

• Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy — Completed